290 related articles for article (PubMed ID: 8025511)
21. A recombinant single-chain immunotoxin composed of anti-Tac variable regions and a truncated diphtheria toxin.
Chaudhary VK; Gallo MG; FitzGerald DJ; Pastan I
Proc Natl Acad Sci U S A; 1990 Dec; 87(23):9491-4. PubMed ID: 2251289
[TBL] [Abstract][Full Text] [Related]
22. New immunotoxins targeting CD123, a stem cell antigen on acute myeloid leukemia cells.
Du X; Ho M; Pastan I
J Immunother; 2007 Sep; 30(6):607-13. PubMed ID: 17667524
[TBL] [Abstract][Full Text] [Related]
23. A recombinant immunotoxin that is active on prostate cancer cells and that is composed of the Fv region of monoclonal antibody PR1 and a truncated form of Pseudomonas exotoxin.
Brinkmann U; Gallo M; Brinkmann E; Kunwar S; Pastan I
Proc Natl Acad Sci U S A; 1993 Jan; 90(2):547-51. PubMed ID: 8421689
[TBL] [Abstract][Full Text] [Related]
24. Recombinant immunotoxin containing a disulfide-stabilized Fv directed at erbB2 that does not require proteolytic activation.
Kuan CT; Pastan I
Biochemistry; 1996 Mar; 35(9):2872-7. PubMed ID: 8608123
[TBL] [Abstract][Full Text] [Related]
25. Targeting Pseudomonas exotoxin to hematologic malignancies.
Kreitman RJ; Pastan I
Semin Cancer Biol; 1995 Oct; 6(5):297-306. PubMed ID: 8562907
[TBL] [Abstract][Full Text] [Related]
26. Recombinant anti-erbB2 immunotoxins containing Pseudomonas exotoxin.
Batra JK; Kasprzyk PG; Bird RE; Pastan I; King CR
Proc Natl Acad Sci U S A; 1992 Jul; 89(13):5867-71. PubMed ID: 1352878
[TBL] [Abstract][Full Text] [Related]
27. Increased cytotoxic activity of Pseudomonas exotoxin and two chimeric toxins ending in KDEL.
Seetharam S; Chaudhary VK; FitzGerald D; Pastan I
J Biol Chem; 1991 Sep; 266(26):17376-81. PubMed ID: 1910044
[TBL] [Abstract][Full Text] [Related]
28. Anti-IL-2 receptor monoclonal antibody (anti-Tac) treatment of T-cell lymphoma.
Waldmann TA
Important Adv Oncol; 1994; ():131-41. PubMed ID: 8206486
[TBL] [Abstract][Full Text] [Related]
29. Rapid humanization of the Fv of monoclonal antibody B3 by using framework exchange of the recombinant immunotoxin B3(Fv)-PE38.
Benhar I; Padlan EA; Jung SH; Lee B; Pastan I
Proc Natl Acad Sci U S A; 1994 Dec; 91(25):12051-5. PubMed ID: 7991583
[TBL] [Abstract][Full Text] [Related]
30. Stabilization of the Fv fragments in recombinant immunotoxins by disulfide bonds engineered into conserved framework regions.
Reiter Y; Brinkmann U; Kreitman RJ; Jung SH; Lee B; Pastan I
Biochemistry; 1994 May; 33(18):5451-9. PubMed ID: 7910034
[TBL] [Abstract][Full Text] [Related]
31. A recombinant immunotoxin consisting of two antibody variable domains fused to Pseudomonas exotoxin.
Chaudhary VK; Queen C; Junghans RP; Waldmann TA; FitzGerald DJ; Pastan I
Nature; 1989 Jun; 339(6223):394-7. PubMed ID: 2498664
[TBL] [Abstract][Full Text] [Related]
32. Hairy cell leukemia, a B-cell neoplasm that is particularly sensitive to the cytotoxic effect of anti-Tac(Fv)-PE38 (LMB-2).
Robbins DH; Margulies I; Stetler-Stevenson M; Kreitman RJ
Clin Cancer Res; 2000 Feb; 6(2):693-700. PubMed ID: 10690555
[TBL] [Abstract][Full Text] [Related]
33. Recombinant single-chain and disulfide-stabilized Fv-immunotoxins that cause complete regression of a human colon cancer xenograft in nude mice.
Reiter Y; Wright AF; Tonge DW; Pastan I
Int J Cancer; 1996 Jul; 67(1):113-23. PubMed ID: 8690511
[TBL] [Abstract][Full Text] [Related]
34. B3(Fv)-PE38KDEL, a single-chain immunotoxin that causes complete regression of a human carcinoma in mice.
Brinkmann U; Pai LH; FitzGerald DJ; Willingham M; Pastan I
Proc Natl Acad Sci U S A; 1991 Oct; 88(19):8616-20. PubMed ID: 1924323
[TBL] [Abstract][Full Text] [Related]
35. Lowering the isoelectric point of the Fv portion of recombinant immunotoxins leads to decreased nonspecific animal toxicity without affecting antitumor activity.
Onda M; Nagata S; Tsutsumi Y; Vincent JJ; Wang Q; Kreitman RJ; Lee B; Pastan I
Cancer Res; 2001 Jul; 61(13):5070-7. PubMed ID: 11431343
[TBL] [Abstract][Full Text] [Related]
36. Novel anti-CD30 recombinant immunotoxins containing disulfide-stabilized Fv fragments.
Nagata S; Onda M; Numata Y; Santora K; Beers R; Kreitman RJ; Pastan I
Clin Cancer Res; 2002 Jul; 8(7):2345-55. PubMed ID: 12114439
[TBL] [Abstract][Full Text] [Related]
37. A recombinant immunotoxin containing a disulfide-stabilized Fv fragment.
Brinkmann U; Reiter Y; Jung SH; Lee B; Pastan I
Proc Natl Acad Sci U S A; 1993 Aug; 90(16):7538-42. PubMed ID: 8356052
[TBL] [Abstract][Full Text] [Related]
38. Immunotoxins in the treatment of refractory hairy cell leukemia.
Kreitman RJ; Pastan I
Hematol Oncol Clin North Am; 2006 Oct; 20(5):1137-51, viii. PubMed ID: 16990113
[TBL] [Abstract][Full Text] [Related]
39. Reduction of the nonspecific animal toxicity of anti-Tac(Fv)-PE38 by mutations in the framework regions of the Fv which lower the isoelectric point.
Onda M; Kreitman RJ; Vasmatzis G; Lee B; Pastan I
J Immunol; 1999 Dec; 163(11):6072-7. PubMed ID: 10570296
[TBL] [Abstract][Full Text] [Related]
40. IL2-PE664Glu, a new chimeric protein cytotoxic to human-activated T lymphocytes.
Lorberboum-Galski H; Garsia RJ; Gately M; Brown PS; Clark RE; Waldmann TA; Chaudhary VK; FitzGerald DJ; Pastan I
J Biol Chem; 1990 Sep; 265(27):16311-7. PubMed ID: 1975810
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
